HRMY: Harmony Biosciences Holdings, Inc.
Performance
HRMY +7.48%
Watchlist
Select an item
Summary
HRMY at a glance
HRMY returned +7.48% over the past year and -4.23% a year over five years. Its worst drop in that year was -34.49%, smaller than 48% of stocks on Redstone, and its Sharpe ratio of 0.29 beats 40% of stocks on Redstone. It pays no dividends.
Current Drawdown
-21.19%
Rolling Volatility
47.94%
Actions
Metrics
Risk Indicators
Alpha6.10%
Beta0.59x
Sharpe0.29
Sortino0.40
Omega1.05
Calmar0.22
Martin0.71
Profile
About HRMY
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $2.0B
- Listed
- Aug 2020
- Employees
- 293
- Headquarters
- Plymouth Meeting, PA
- Website
- harmonybiosciences.com
Comparisons